NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patientsSunny Malhotra, Manuel Comabella, Lukas Amman et al.|Brain|2020Cited by 136
NLRP3 inflammasome is associated with the response to IFN-β in patients with multiple sclerosisSunny Malhotra, Manuel Comabella, Jordi Río et al.|Brain|2015Cited by 110